Innovative approach highlighted at 2018 Asia Pacific Energy Assembly SINGAPORE-Friday, January 26th 2018 [ AETOS Wire ] (BUSINESS WIRE) -- AG&P (Atlantic, Gulf and Pacific Company), the Philippines-based company at the forefront of developing pragmatic, end-to-end LNG delivery solutions, says demand aggregation is the key to growing and unlocking the market for gas. The power sector continues to be the key driver for growing global gas demand. However, liquid-fuelled power plants are typically too small to be viably served on a standalone basis. Leveraging AG&P’s innovative, standardized LNG supply chain solutions, AG&P aggregates downstream demand to achieve the minimum throughput required to unlock gas-to-power markets. AG&P singularly provides a fully integrated solution from LNG sourcing to last-mile delivery, thus simplifying and making commercially compelling the decision to switch energy sources for its customers. AG&P’s business model is unique by bringing under one p ... Read more »

SAINT-PREX, Switzerland -Friday, January 26th 2018 [ AETOS Wire ] (BUSINESS WIRE)-- Ferring Pharmaceuticals today announced the recipients of the 2017-2018 Innovation Grants Program, an annual initiative of the Ferring Research Institute (FRI) based in San Diego. This global program supports research in the fields of reproductive medicine and women’s health, urology, gastroenterology, hepatology, and endocrinology. “The quality of applications received in response to the 2017-2018 Ferring Innovation Grants call for proposals was outstanding. We have funded programs that we believe represent the leading edge of research in their therapeutic fields, and very much look forward to seeing the outcome of the innovative projects proposed by this year’s grant awardees,” said Keith James, President Ferring Research Institute, Senior Vice President Research and Development. Now in its fifth year, the Innovation Grants Program received 300 submissions. Each submission was reviewed for its scie ... Read more »

Team Visa athletes give their followers a first look at their journey to PyeongChang 2018 and how Visa’s innovative payment products are helping along the way SAN FRANCISCO-Friday, January 26th 2018 [ AETOS Wire ] (BUSINESS WIRE) -- With less than one month until the Olympic Winter Games PyeongChang 2018 Opening Ceremony, Visa’s (NYSE: V) roster of Team Visa athletes took the lead in launching the brand’s full-length 60-second global advertising campaign, “Resetting Finish Lines,” across their personal social media accounts. Over the past week, all 54 members of the Team Visa roster, including Olympic and Paralympic athletes, hopefuls, and legends representing twenty-one (21) countries and fifteen (15) sports, premiered the full-length spot ahead of its traditional debut on global digital and broadcast channels to highlight their appreciation for the support they’ve received during their training for PyeongChang 2018. “Creating a film and inviting Team Visa athletes to be the stars ... Read more »

European Commission Approves ADCETRIS® (brentuximab vedotin) for CD30-Positive Cutaneous T-Cell Lymphoma after One Prior Systemic Therapy– Providing an Innovative Treatment Option to Patients – Approval based on positive Phase 3 ALCANZA study results, which demonstrated a highly statistically significant improvement in rate of objective response lasting at least four months, median progression-free survival and overall response rate, and improvement in symptom burden in ADCETRIS arm – – Milestone further reinforces the role of ADCETRIS in improving outcomes for patients with CD30-positive malignancies – CAMBRIDGE, Mass. & OSAKA, Japan-Friday, January 26th 2018 [ AETOS Wire ] (BUSINESS WIRE) -- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Commission (EC) extended the current conditional marketing authorization of ADCETRIS® (brentuximab vedotin) and approved ADCETRIS for the treatment of adult patients with CD30-positive cutaneous T-cell lymp ... Read more »

Deals include a 70% stake in a cosmetic medicine provider worth $170m, says NMC Health Abu Dhabi, United Arab Emirates.-Monday, January 22nd 2018 [ AETOS Wire ] UAE healthcare operator NMC Health plc has announced two new acquisitions and the completion of new operating and management (O&M) contract as the company moves to expand across the Middle East. Among the acquisitions are a 70 percent stake in CosmeSurge, a cosmetic surgery and aesthetic medicine provider. According to NMC, the acquisition is worth $170 million. NMC also signed a new O&M contracts with Emirates Healthcare Group to manage its Egyptian hospitals, Dar Al Fouad and As Salam International. The deal is expected to generate revenues of $2 million for NMC in the first year of operation. In a statement, NMC noted that the transaction includes a chain of 17 operational clinics, with the business expected to deliver 2017 revenues and EBIDTA of $67 million and $20.5 million, respectively. NMC also acquired an 80 perc ... Read more »